Printer Friendly

Browse Fibrinolytic agents topic


1-110 out of 110 article(s)
Title Author Type Date Words
An Evaluation of the Effect of the Clinical Features of Patients and the Drugs Used on the False-Positive EIA Test for HIV. Orak, Filiz; Doganer, Adem; Yalcinkaya, Kezban Tulay; Aral, Murat Report Sep 1, 2021 3738
Effcacy and Safety of Switching from Clopidogrel to Ticagrelor at the Time of Discharge in STEMI Patients Treated with a Pharmacoinvasive Approach. Coner, Ali; Muderrisoglu, Ibrahim Haldun Report Aug 6, 2021 4698
Risk of colonoscopic post-polypectomy bleeding in patients after the discontinuation of antithrombotic therapy. Kishino, Takaaki; Oyama, Tsuneo; Hotta, Kinichi; Ishii, Eiji; Momoi, Tamaki; Shimizu, Takehiro; Kuni Report Nov 1, 2020 4934
Multicenter Study of the Hemorrhage Risk after Endoscopic Mucosal Resection Associated with Direct Oral Anticoagulants. Yasuda, Ritsu; Yoshida, Naohisa; Murakami, Takaaki; Hirose, Ryohei; Inoue, Ken; Dohi, Osamu; Naito, Report Dec 31, 2019 4961
Plasma Fibrin Clot Properties Are Unfavorably Altered in Women following Venous Thromboembolism Associated with Combined Hormonal Contraception. Pirog, Magdalena; Piwowarczyk, Slawomir; Undas, Anetta Dec 31, 2019 6325
Frequency and factors related to not receiving acute reperfusion therapy in patients with ST elevation myocardial infarction; a single specialty cardiac center. Report Sep 30, 2019 3984
Evaluation of Anticoagulant Proteins and Fibrinolytic System Markers in Children with Pneumonia. Yalaki, Zahide; Alioglu, Bulent; Ciftci, Nurdan; Arikan, Fatma Inci Report Mar 1, 2019 3188
Production of fibrinogenolytic and fibrinolytic enzymes by a strain of Penicillium sp. isolated from contaminated soil with industrial effluent. Baggio, Maria Lillian; Panagio, Luciano Aparecido; Gasparin, Fabiana Guillen Moreira; Sartori, Danie Jan 1, 2019 5094
Plasminogen Activator Inhibitor 1 as a Poor Prognostic Indicator in Resectable Pancreatic Ductal Adenocarcinoma. Liu, Wen-Jing; Zhou, Li; Liang, Zhi-Yong; Zhou, Wei-Xun; You, Lei; Zhang, Tai-Ping; Zhao, Yu-Pei Report Dec 20, 2018 3386
Clinical efficacy of low dose recombinant tissue-type plasminogen activator for the treatment of acute intermediate-risk pulmonary embolism. Zhang, Ling-Yun; Gao, Bao-An; Jin, Zhu; Xiang, Guang-Ming; Gong, Zheng; Zhang, Ting-Ting; Lu, Hong-F Nov 1, 2018 3558
Plasminogenemia asociada a conjuntivitis lenosa. de Castro Hernandez, Melissa; Alvarez Guevara, Angelica Natalia; De los Reyes Valencia, Iliana Jul 1, 2018 2635
Assessment of anti-coagulation knowledge in Sudanese patients with non-valvular atrial fibrillation. Mokhtar, Mawahib Hassan; Nourein, Ihab Hamed Report Jul 1, 2018 2370
Lumbrokinase--An Enzyme for More Than Just Circulatory Health! Kwok, Martin Report May 1, 2018 3450
Streamlining the Process for Intravenous Tissue Plasminogen Activator. Lawrence, Erin; Merbach, Dawn; Thorpe, Sherry; Llinas, Rafael H.; Marsh, Elisabeth B. Report Feb 1, 2018 2796
Production of Fibrinolytic Enzyme by the Marine Isolate Serratia marcescens subsp. sakuensis and its In-vitro Anticoagulant and Thrombolytic Potential. Krishnamurthy, Anusha; Belur, Prasanna Devarbhat; Rai, Prachi; Rekha, Punchappady Devasya Report Dec 1, 2017 6739
Current Use of Oral Anticoagulants and Prognostic Analysis in Patients with Atrial Fibrillation Undergoing Coronary Stenting. Zhai, Heng-Bo; Liu, Jun; Dong, Zhi-Chao; Wang, Dong-Xia; Zhang, Bo Jul 27, 2017 3681
Variations of Postresuscitation Lung Function after Thrombolysis Therapy in a Cardiac Arrest Porcine Model Caused by Pulmonary Thromboembolism. Yang, Jun; Zhao, Lian-Xing; Li, Chun-Sheng; Tong, Nan; Xiao, Hong-Li; An, Le Report Jul 27, 2017 4340
Prometic announces completion of the plasminogen BLA filing with the US FDA. Apr 6, 2017 257
Prometic announces completion of the plasminogen BLA filing with the US FDA. Apr 6, 2017 253
Iatrogenic IVC Perforation after Successful Catheter-Directed Thrombolysis. Firoozi, Ata; Moosavi, Jamal; Shafe, Omid; Sadeghipour, Parham Case study Jan 1, 2017 1369
Aspalatone Prevents VEGF-Induced Lipid Peroxidation, Migration, Tube Formation, and Dysfunction of Human Aortic Endothelial Cells. Sonowal, Himangshu; Pal, Pabitra B.; Shukla, Kirtikar; Ramana, Kota V. Report Jan 1, 2017 6962
Transient Expression of Lumbrokinase (PI239) in Tobacco (Nicotiana tabacum) Using a Geminivirus-Based Single Replicon System Dissolves Fibrin and Blood Clots. Dickey, Alexia; Wang, Nan; Cooper, Edwin; Tull, Lauren; Breedlove, Drew; Mason, Hugh; Liu, Dehu; Wan Jan 1, 2017 5661
Phase I and Phase II Therapies for Acute Ischemic Stroke: An Update on Currently Studied Drugs in Clinical Research. Reis, Cesar; Akyol, Onat; Ho, Wing Mann; Araujo, Camila; Huang, Lei; Richard, Applegate II; Zhang, J Report Jan 1, 2017 11052
Where does the time go? The effect of protocols for stroke last known well documentation on intravenous recombinant tissue plasminogen activator delivery in the Northeast. Zanichkowsky, Rita; Nascimento, Jennifer A.; McCune, Marie; Spencer, Cynthia; Chukwuneke, Florence; Report Apr 1, 2016 2737
Antithrombotic and antiinflammatory effect of heparin conjugated poly(l-lactide) on inflammation induced cyclooxygenase. Mandal, Ramila D.; Patel, Payal J.; Patel, Nisha R.; Patel, Himanshu J.; Kale, Sunil P.; Engineer, C Report Apr 1, 2016 3488
Time to fibrinolytics for acute myocardial infarction: reasons for delays at Steve Biko Academic Hospital, Pretoria, South Africa. Meel, R.; Goncalves, R. Report Jan 1, 2016 3844
Time to blood pressure control before thrombolytic therapy in patients with acute ischemic stroke: comparison of labetalol, nicardipine, and hydralazine. McKay, Courtney; Hall, A. Brad; Cortes, Jennifer Report Dec 1, 2015 3646
Impact of fibrinolytics on the outcome of empyema in South African children. Zampoli, M.; Kappos, A.; Verwey, C.; Mamathuba, R.; Zar, H.J. Report Jul 1, 2015 4085
Impact of Oral Thrombolysis After Catheter-based Thrombectomy in Acute and Subacute Submassive Pulmonary Thromboembolism. Ahmed, Khurshid; Munawar, Muhammad; Munawar, Dian; Hartono, Beny Clinical report Mar 1, 2015 1574
Blood thinners and your brain. Nov 1, 2014 774
ProMetic Life Sciences' IV plasminogen receives approval from US FDA. Oct 30, 2014 112
ProMetic Life Sciences' IV plasminogen receives approval from US FDA. Oct 30, 2014 108
Clinical value of plasma soluble urokinase-type plasminogen activator receptor levels in term neonates with infection or sepsis: a prospective study. Siahanidou, Tania; Margeli, Alexandra; Tsirogianni, Chrysanthi; Charoni, Stavroula; Giannaki, Maria; Jan 1, 2014 4965
Functional stability of plasminogen activator inhibitor-1. Yildiz, Songul Yasar; Kuru, Pinar; Oner, Ebru Toksoy; Agirbasli, Mehmet Report Jan 1, 2014 9449
Optimal timing for resuming antithrombotic agents and risk factors for delayed bleeding after endoscopic resection of colorectal tumors. Beppu, Kazuko; Osada, Taro; Sakamoto, Naoto; Shibuya, Tomoyoshi; Matsumoto, Kenshi; Nagahara, Akihit Report Jan 1, 2014 3372
Ligneous conjunctivitis: case series/Lignoz konjonktivit: olgu serisi. Ozcura, Fatih; Yildirim, Nilgun; Basmak, Hikmet; Ciftci, Evrim Report Nov 1, 2013 2445
Soluble urokinase plasminogen activator receptor for risk prediction in patients admitted with acute chest pain. Lyngbaek, Stig; Andersson, Charlotte; Marott, Jacob L.; Moller, Daniel V.; Christiansen, Michael; Iv Report Nov 1, 2013 6661
Characterization of Escherichia coli as a plasminogen-binding protein. Gonzalez, Tammy; Gaultney, Robert A.; Floden, Angela M.; Brissette, Catherine A. Apr 1, 2013 392
Prompt delivery of Thrombolytic therapy: Experience with chest pain units and emergency medical services. Clinical report Feb 28, 2013 3053
Plasmin activation of glial cells through protease-activated receptor 1. Greenidge, Andre R.; Hall, Kiana R.; Hambleton, Ian R.; Thomas, Richelle; Monroe, Dougald M.; Landis Report Jan 1, 2013 4386
Antiplatelet and antithrombotic activity of indole-3-carbinol in vitro and in vivo. Brief article Jan 1, 2013 145
Neuroendovascular treatments/procedures: are they efficacious and have they improved patient outcomes poststroke? Holmes, Timbolin D. Report Oct 1, 2012 7581
Tissue plasminogen activator and plasminogen activator inhibitor-1 levels in patients with acute myocardial infarction and unstable angina. Habib, Syed Shahid; Gader, Abdel Galil Mohamad Abdel; Kurdi, Mohammad Ibrahim; Suriya, Mohammad Owai Report Jul 31, 2012 3872
Door-to-needle time for administration of fibrinolytics in acute myocardial infarction in Cape Town. Maharaj, Roshen C.; Geduld, Heike; Wallis, Lee A. Report Apr 1, 2012 3783
Analyze the native form of plasminogen in bovine milk. Dec 1, 2010 358
Activity of plasmin and plasminogen in ultra high temperature milk with high and low somatic cell counts during storage/Atividade de plasmina e plasminogenio no leite longa vida com alta e baixa contagem de celulas somaticas durante o armazenamento. Corassin, Carlos Humberto; Rosim, Roice Eliana; de Oliveira, Carlos Augusto Fernandes Dec 1, 2010 3593
Nostrum to in-license thrombolytics from IMTECH. Nov 25, 2010 207
Q/ What's the best way to manage upper extremity venous thrombosis? Rabens, Clayton; Goodemote, Patricia; Jamieson, Barbara Report Aug 1, 2010 981
Lundbeck S/A. Brief article Mar 1, 2010 117
Downregulation of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 by grape seed proanthocyanidin extract. Sandra, Dhungana; Radha, Madhyastha; Harishkumar, Madhyastha; Yuichi, Nakajima; Sayuri, Omura; Masug Report Jan 1, 2010 3330
People who have had a common kind of heart attack should get artery-clearing angioplasty within six hours after taking clot-busting drugs to prevent more damage, a study found. Brief article Jun 29, 2009 237
Nattokinase for Hypertension. Brief article Jun 1, 2009 188
Stroke tied to withdrawal of antithrombotics. Finn, Robert Brief article Apr 15, 2009 275
Implementation of a nursing intervention checklist for hemodialysis permanent catheter dysfunction. Jenkins, Margaret; Wyton, Twylla-Dawn; Maltby, Sherry; Cameron, Valerie; McCallum, Charlotte; Thomps Brief article Jul 1, 2008 253
Establishing a stroke response team in a rural setting. Justice, Julie Sain; Howe, Linda A.; Dyches, Cathy; Heifferon, Barbara A. Mar 22, 2008 4123
Production & purification of a fibrinolytic enzyme (thrombinase) from Bacillus sphaericus. Balaraman, K.; Prabakaran, G. Clinical report Nov 1, 2007 3195
Nuvelo Corp. (Nasdaq) led advancing issues, leaping 46 cents, or 29% for the week, to $2.06. The biotech company said it re-initiated its Sonoma-3 study on Alfimeprase in patients with catheter occlusion. Brief article Aug 27, 2007 225
Hitting the target with antithrombotic therapy. Fritsma, Margaret G.; Rodak, Bernadette F. May 1, 2007 3070
Stroke prevention tops new atrial fib guidelines. Zoler, Mitchel L. Clinical report Oct 1, 2006 735
Purification of c-phycocyanin from Spirulina fusiformis and its effect on the induction of urokinase-type plasminogen activator from calf pulmonary endothelial cells. Madhyastha, H.K.; Radha, K.S.; Sugiki, M.; Omura, S.; Maruyama, M. Sep 1, 2006 3033
Bivalirudin may reduce need to use IIb/IIIa agents in ACS. Zoler, Mitchel L. May 1, 2006 937
Who should get long-term venous prophylaxis? MacNeil, Jane Salodof Statistical data Mar 1, 2006 698
Who should get long-term venous prophylaxis? Studies are needed to identify the risk factors for the recurrence of pulmonary embolism. MacNeil, Jane Salodof Dec 1, 2005 758
Fondaparinux bests enoxaparin overall in ACS. Jancin, Bruce Nov 1, 2005 971
Fondaparinux betters enoxaparin in acute coronary syndrome. Jancin, Bruce Nov 1, 2005 1012
MRI buys time for thrombolysis of acute stroke. Zoler, Mitchel L. Jun 15, 2005 824
Desmoteplase could extend thrombolysis treatment window. Wachter, Kerri Jun 15, 2005 411
New drugs on the horizon for VTE. Wakefield, Thomas Editorial Jun 1, 2005 772
Favorable MRI buys time for thrombolysis of acute stroke. Zoler, Mitchel L. Mar 15, 2005 761
Desmoteplase could widen thrombolysis therapy time frame. Wachter, Kerri Mar 15, 2005 411
Thrombolysis safe, effective for stroke after cardiac cath. Zoler, Mitchel L. Mar 15, 2005 417
Thrombolysis-induced ocular bleeding. Moon, Mary Ann Brief Article Mar 15, 2005 110
In vitro induction of endothelial cell fibrinolytic alterations by Nigella sativa. Awad, E.M.; Binder, B.R. Mar 1, 2005 6295
Low-molecular-weight heparin may aid acute MI: reviparin improved patient outcomes in thrombolysis with streptokinase or urokinase. Zoler, Mitchel L. Mar 1, 2005 816
DVT prophylaxis following orthopedic surgery. Zoler, Mitchel L.; Brunk, Doug Feb 1, 2005 1028
When thrombolysis is the sole option. Moon, Mary Ann Brief Article Jan 15, 2005 164
Cryptome anti-thrombosis drug reduces clots in animals. Jan 1, 2005 547
Treating basilar artery occlusion. Moon, Mary Ann Brief Article Dec 1, 2004 201
Antithrombosis guidelines give travel advice. Kirn, Timothy F. Oct 15, 2004 824
When should patients with stroke receive thrombolytics? Adair, Gina; Grant, Joel; Pandhi, Nancy; Saunders, Robert; Sadowsky, Iris; West, Brian; Kerns, J. Wi Aug 1, 2004 1319
Aspirin, more hospitalizations linked in heart failure patients: comparing antithrombotic drugs. Zoler, Mitchel L. May 1, 2004 766
Out-of-hospital cardiac arrest: thrombolytic therapy during CPR put to the test. Jancin, Bruce Brief Article Apr 1, 2004 245
Importance of formal treatment guidelines brought to the fore by VTE: success story from Toronto. Brunk, Doug Mar 15, 2004 300
Fondaparinux may lead to fewer complications. Kirn, Timothy F. Mar 15, 2004 444
Direct thrombin inhibitor prevents recurrent deep vein thrombosis: ximelagatran. Kirn, Timothy F. Mar 1, 2004 350
Thrombolytic therapy may be beneficial in out-of-hospital CPR: planned randomized trial. (cardiopulmonary resuscitation). Jancin, Bruce Dec 15, 2003 311
Fast stroke treatment saves lives. Zipes, Douglas Aug 1, 2003 369
CryoLife subsidiary AuraZyme awarded NIH grant to study advanced clot-dissolving technology. Brief Article Mar 31, 2003 101
Quantitative real-time reverse transcription-PCR assay for urokinase plasminogen activator, plasminogen activator inhibitor type 1, and tissue metalloproteinase inhibitor type 1 gene expressions in primary breast cancer. Castello, Remedios; Estelles, Amparo; Vazquez, Carlos; Falco, Cristina; Espana, Francisco; Almenar, Aug 1, 2002 5185
Novel tumor markers for node-negative cancer. (Clinical Rounds: Defines need for chemotherapy). Jancin, Bruce Brief Article Apr 1, 2002 570
Clot busters may put elderly people at risk. (Biomedicine). Brief Article Mar 23, 2002 275
Prehospital Reteplase Safely Shaves 30 minutes off time to MI Treatment. (ER TIMI-19). Jancin, Bruce Jan 1, 2002 384
Occluded Venous Catheters Salvaged by Alteplase. JANCIN, BRUCE Brief Article Sep 1, 2001 344
Is ticlopidine more effective than aspirin in preventing adverse cardiovascular events after myocardial infarction (MI)? Olson, John; Huntington, Jane Jul 1, 2001 731
Conservative vs. Aggressive Treatment. Brief Article Feb 1, 2001 511
Biolink patents prevention of infection and blood clotting in prosthetic medical devices. Feb 1, 2001 547
GP IIb/IIIa Inhibitors Safe With Enoxaparin. JANCIN, BRUCE Oct 15, 2000 503
Enoxaparin Beats Heparin in Inpatients for VTE Prophylaxis. CHENG, GUANG-SHING Feb 15, 2000 841
Thrombophilia Associated With Pregnancy Loss. CHENG, GUANG-SHING Brief Article Feb 1, 2000 471
Inhaled Enoxaparin Decreases Bronchoconstriction in Asthmatics. Cheng, Guang-Shing Brief Article Jan 1, 2000 195
Useful laboratory tests for studying thrombogenesis in acute cardiac syndromes. Fareed, Jawed; Hoppensteadt, Debra A.; Leya, Fred; Iqbal, Omer; Wolf, Helmut; Bick, Roger Aug 1, 1998 6272
Merck Wins Okay to Market 'Super Aspirin'. Jun 29, 1998 445
Merck Wins Okay to Market 'Super Aspirin' Article Jun 29, 1998 445
Neuroprotective and thrombolytic agents: advances in stroke treatment. Hock, Nanette Jun 1, 1998 7177
Rebound increase of plasminogen activator inhibitor type I after cessation of thrombolytic treatment for acute myocardial infarction is independent of type of plasminogen activator used. Genser, Norbert; Lechleitner, Peter; Maier, Josef; Dienstl, Franz; Artner-Dworzak, Erika; Puschendor Feb 1, 1998 3485
Thrombolysis for elderly patients with myocardial infarction: experience in an integrated unit. Batty, Gwenno M.; Parry, D.S.; Wilkins, W.E.; Chappell, A.G. May 1, 1994 1963
Blood substances linked to heart risk. Fackelmann, Kathy A. Brief Article Nov 20, 1993 322
When clot-busting drugs aren't working. Oct 1, 1993 460
Bless the vampires, leeches, and other bloodsuckers! Oct 1, 1991 437
Thrombolytic therapy during active menstruation: a case report. Chop, William M., Jr.; Evans, Patrick J.; Felty, Kelly Jul 1, 1991 1586

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters |